aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.9598
-0.0302 (-3.05%)
At close: Feb 27, 2026, 4:00 PM EST
0.9500
-0.0098 (-1.02%)
After-hours: Feb 27, 2026, 7:56 PM EST
aTyr Pharma Employees
As of December 31, 2024, aTyr Pharma had 65 total employees, including 56 full-time and 9 part-time employees. The number of employees increased by 6 or 10.17% compared to the previous year.
Employees
65
Change (1Y)
6
Growth (1Y)
10.17%
Revenue / Employee
$2,923
Profits / Employee
-$1,155,723
Market Cap
94.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 65 | 6 | 10.17% | 56 | 9 |
| Dec 31, 2023 | 59 | -11 | -15.71% | 56 | 3 |
| Dec 31, 2022 | 70 | 17 | 32.08% | 65 | 5 |
| Dec 31, 2021 | 53 | 10 | 23.26% | 49 | 4 |
| Dec 31, 2020 | 43 | -1 | -2.27% | 40 | 3 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 188 |
| Gossamer Bio | 145 |
| Precision BioSciences | 67 |
| Pyxis Oncology | 44 |
| Vivani Medical | 37 |
| Cognition Therapeutics | 28 |
| Gain Therapeutics | 25 |
| TuHURA Biosciences | 19 |
ATYR News
- 2 days ago - Ethos to Participate in The Citizens Technology Conference - GlobeNewsWire
- 3 days ago - Ethos Technologies Inc. (LIFE) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 8 days ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 23 days ago - Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 25 days ago - The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts. - Barrons
- 25 days ago - aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis - GlobeNewsWire